🇺🇸 FDA
Company

vTv

vTv Therapeutics

VTVT pharma USA

Quick answer

vTv is a pharma company (VTVT) headquartered in HIGH POINT, NC, USA with 14 tracked pipeline programs.

Pipeline (14)

project

Azeliragon

Alzheimer's Disease

Phase 3 · small_molecule · terminated

1 trials project

Azeliragon 5mg

Alzheimer's Disease

Phase 3 · small_molecule · terminated

1 trials project

Cadisegliatin 800 mg QD

Diabetes Mellitus, Type 1

Phase 3 · small_molecule · active

1 trials project

Azeliragon

Alzheimer Disease

Phase 2 · small_molecule · terminated

1 trials project

GK1-399 (formerly TTP399)

Type 2 Diabetes Mellitus

Phase 2 · small_molecule · completed

1 trials project

TTP054

Type 2 Diabetes Mellitus

Phase 2 · small_molecule · completed

1 trials project

TTP273

Type 2 Diabetes Mellitus

Phase 2 · small_molecule · completed

1 trials project

TTP399

Diabetes Mellitus, Type 1

Phase 2 · small_molecule · completed

1 trials project

TTP399 400 mg

Diabetes Mellitus, Type 2

Phase 2 · small_molecule · completed

1 trials project

TTP435

Obesity

Phase 2 · small_molecule · completed

1 trials project

TTP889

Coagulation

Phase 2 · small_molecule · terminated

1 trials project

TTP889

Venous Thromboembolism

Phase 2 · small_molecule · completed

1 trials project

TTP4000

Alzheimer's Disease

Phase 1 · small_molecule · completed

1 trials project

TTP607

Advanced Cancers

Phase 1 · small_molecule · terminated

1 trials

Patents (8)

patent

US 12391658

Sulfoxide and sulfone glucokinase activators and methods of use thereof

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12091407

Substituted fused imidazole derivatives, pharmaceutical compositions, and method

Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11974989

Therapeutic uses of glucokinase activators in combination with insulin or insuli

Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11970457

Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-

Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11883383

Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phe

Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11833136

Therapeutic uses of glucokinase activators in combination with insulin or insuli

Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11649230

Substituted fused imidazole derivatives, pharmaceutical compositions, and method

Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11524942

Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-

Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)